Analysis Group Consultants to Present at ISPOR 2026
Event:ISPOR 2026
Dates:
May 17–20, 2026
Host:
ISPOR – The Professional Society for Health Economics and Outcomes Research
Location:
Philadelphia, PA
Analysis Group, a global leader in health economics and outcomes research (HEOR), epidemiology, and market access, will present an educational symposium, join two panel discussions, contribute to a podium presentation, and share 25 research posters at ISPOR 2026, which will be held at the Pennsylvania Convention Center in Philadelphia, PA.
Managing Principal Eric Wu, Principal Jimmy Royer, and Professor Liming Liang (Harvard T.H. Chan School of Public Health) will present an educational symposium titled “Driving the Next Era of Evidence-Based Medicine through AI, Diverse Data, and Collaboration.” The symposium will explore how cutting-edge GenAI methodology can be applied to develop comprehensive and up-to-date insights on diseases and treatment outcomes from heterogeneous data sources. Presenters will showcase the application of GenAI with digital twin methodologies to simulate the long-term progression of obesity and chronic cardiometabolic diseases.
The symposium will also introduce a new real-world evidence research initiative jointly launched by the Harvard T.H. Chan School of Public Health and Analysis Group, focused on advancing precision health through the application of AI to better understand disease pathways, treatment effectiveness, and personalized health. The symposium will be held on Tuesday, May 19, at 12:15 p.m.
Additional presentations:
- Managing Principal Min Yang will participate as a panelist in the forum titled “HEOR Skills Building: Essential Skills for the Future” on Monday, May 18, at 12:15 p.m.
- Principal Jimmy Royer will participate as a panelist in the forum titled “The Enduring Challenge of Medical Device Identification in Real-World Data: Is Artificial Intelligence Abstraction Ready for Broad Use and Acceptance?” on Monday, May 18, at 12:15 p.m.
- A study coauthored by Vice President Weiguang Xue, Manager Yanwen Xie, and Senior Analyst Jack Eales titled “Consideration of Indirect Effects in National Vaccine Evaluations and Recommendations: A Scoping Review” will be shared as a podium presentation on Monday, May 18, at 1:45 p.m.
Further details on these presentations and Analysis Group’s posters are available in our ISPOR 2026 Presentation Guide.